基于 PubMed 数据库对梅尼埃病的聚类分析
唱得龙 - 中国医学创新, 2018
… 摘要:目的:探索分析近十年对梅尼埃病的研究热点。方法:选用PubMed数据库,
检索式为"Meniere Disease"[Mesh]AND("2007/11/11"[PDat]:"2017/11/07"[
PDat]),检索结果采用书目信息挖掘系统(BICOMS)软件进行常规文献计量 …
检索式为"Meniere Disease"[Mesh]AND("2007/11/11"[PDat]:"2017/11/07"[
PDat]),检索结果采用书目信息挖掘系统(BICOMS)软件进行常规文献计量 …
BENEFITS OF SUPPLEMENTATION WITH N-ACETYLCYSTEINE AND GLYCINE TO IMPROVE GLUTATHIONE LEVELS
S Kirnon, E Freedland, RV Sekhar - US Patent App. 15/577,422, 2018
… hypertension; polycystic ovary syndrome; atherosclerosis; coronary artery
disease, myocardial damage after stress; insufficient immunity following
vaccination; cystic fibrosis; traumatic brain injury; concussion; ototoxicity …
disease, myocardial damage after stress; insufficient immunity following
vaccination; cystic fibrosis; traumatic brain injury; concussion; ototoxicity …
Bioactive Organoselenium Compounds and Therapeutic Perspectives
EJ Lenardão, C Santi, L Sancineto - New Frontiers in Organoselenium Compounds, 2018
… loss. 32. [45]. 2011 a. Otoprotection with SPI-1005 for prevention of temporary auditory
threshold shift. 83. NCT01444846 b. 2015 a. Study to evaluate SPI-1005 in adults
with Meniere's disease. 40. NCT02603081 b. 2016. Effects of …
threshold shift. 83. NCT01444846 b. 2015 a. Study to evaluate SPI-1005 in adults
with Meniere's disease. 40. NCT02603081 b. 2016. Effects of …
[PDF] ADBI Working Paper Series
IPOFS MODULES - 2018
… technology models. As Glachant, Meniere, and Arnaud (2013) state in their paper,
the experience curve effect plays a huge part in both the government's renewable
energy policy discussions and solar PV manufacturing. However …
the experience curve effect plays a huge part in both the government's renewable
energy policy discussions and solar PV manufacturing. However …
EMESIS TREATMENT
D Helton, J Lucot - US Patent App. 15/894,724, 2018
… compounds are beneficial in the treatment of acute, delayed or anticipatory
emesis, including emesis induced by chemotherapy, radiation, toxins, viral
or bacterial infections, pregnancy, vestibular disorders (eg motion sickness …
emesis, including emesis induced by chemotherapy, radiation, toxins, viral
or bacterial infections, pregnancy, vestibular disorders (eg motion sickness …
CONTROLLED RELEASE ANTIMICROBIAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
J Lichter, AM Trammel, F Piu, Q Ye, LA Dellamary… - US Patent App. 15/710,727, 2018
… ear. Otic disorders treatable with the formulations disclosed herein include otitis
externa, otitis media, Ramsay Hunt syndrome, otosyphilis, autoimmune inner ear
disease (AIED), Meniere's disease, and vestibular neuronitis …
externa, otitis media, Ramsay Hunt syndrome, otosyphilis, autoimmune inner ear
disease (AIED), Meniere's disease, and vestibular neuronitis …
METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF HEARING LOSS
J Zuo, T Teitz, J Fang, A Goktug, T Chen, J Min, KR Guy - US Patent App. 15/580,224, 2018
… are not limited to, induced or spontaneous vertigo, dysequilibrium, increased
susceptibility to motion sickness, nausea, vomiting, ataxia, labyrinthitis,
oscillopsia, nystagmus, syncope, lightheadedness, dizziness, increased falling …
susceptibility to motion sickness, nausea, vomiting, ataxia, labyrinthitis,
oscillopsia, nystagmus, syncope, lightheadedness, dizziness, increased falling …
[HTML] Gastroenterologia y Hepatologia. Problemas Comunes en La Practica Clinica
YC Alcedo
… aguda intermitente ❱❱ Alteraciones del SNC • Migraña • Hipertensión
endocraneal – Tumores cerebrales – Hemorragia cerebral o cerebelosa –
Absceso cerebral – Hidrocefalia • Alteraciones vestibulares – Laberintitis …
endocraneal – Tumores cerebrales – Hemorragia cerebral o cerebelosa –
Absceso cerebral – Hidrocefalia • Alteraciones vestibulares – Laberintitis …
COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
M Fotin-mleczek, P Baumhof - US Patent App. 15/885,750, 2018
The present invention relates to a complexed RNA, comprising at least one
RNA complexed with one or more oligopeptides, wherein the oligopeptide,
which has the function of cell-penetrating peptide (CP.
RNA complexed with one or more oligopeptides, wherein the oligopeptide,
which has the function of cell-penetrating peptide (CP.
COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
M Fotin-mleczek, P Baumhof - US Patent App. 15/884,695, 2018
The present invention relates to a complexed RNA, comprising at least one
RNA complexed with one or more oligopeptides, wherein the oligopeptide,
which has the function of cell-penetrating peptide (CP.
RNA complexed with one or more oligopeptides, wherein the oligopeptide,
which has the function of cell-penetrating peptide (CP.
Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου